Ovid Therapeutics Inc. Other Non-Current Assets
Ovid Therapeutics Inc. (OVID) had Other Non-Current Assets of $0 as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-03-18
- 2025-12-31: Other Assets, Noncurrent $0.00.
- 2025-09-30: Other Assets, Noncurrent $0.00.
- 2025-06-30: Other Assets, Noncurrent $0.00.
- 2025-03-31: Other Assets, Noncurrent $39.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-18 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $39.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $92.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $182.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $246.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $174.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $210.00K 10-K · filed 2025-03-11 | $209.57K 10-K · filed 2024-03-08 |
| 2023-09-30 | $248.65K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $289.97K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $212.51K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $261.19K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $275.45K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $328.80K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $244.03K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $260.13K 10-K · filed 2023-03-13 | $164.09K 10-K · filed 2022-03-15 |
| 2021-09-30 | $197.15K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $227.43K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $262.81K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $318.90K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $360.96K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $375.82K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $436.29K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $467.25K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $351.27K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $270.95K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $331.10K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $391.87K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $406.08K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $313.33K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $160.39K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $124.19K 10-K · filed 2019-03-07 | $728.84K 10-K · filed 2018-03-29 |
| 2017-09-30 | $207.66K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $215.75K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $200.28K 10-Q · filed 2017-06-13 | |
| 2016-12-31 | $165.30K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |